Zebra print ribbon

Last updated
Zebra ribbon.svg

The zebra print ribbon is the awareness ribbon for uncommon or rare diseases and cancers including but not limited to neuroendocrine tumors, carcinoid cancer, Ehlers-Danlos Syndromes, Whipple's disease and awareness of other rare diseases, cancers and disorders.

Contents

Origin

The zebra has been used as a symbol for rare diseases since around 1940. Dr. Theodore Woodward, a professor at the University of Maryland's School of Medicine [1] used this term to teach students the basics of diagnosing disease: "When looking at a patient's symptoms, it is better to assume it is a common ailment, not a rare one – a horse rather than a zebra." [1]

Usage

Rare diseases and National Rare Disease Day

National Rare Disease Day (also known as Rare Disease Awareness Day) is held on February 29, but is moved up a day to February 28 on non-leap years. [2] [3] This day was launched by the European Organization for Rare Diseases in 2008 [4] [5] and is now recognized worldwide. The date of February 29 was chosen because it is a "rare day" due to the leap year. [6] The symbol for rare disease awareness is a black and white striped ribbon. [7]

In the US, the National Organization for Rare Disorders brings to light rare diseases, listing and defining more than 1,200 rare diseases that fall under the zebra awareness ribbon. [8]

One of the rarest diseases on the list is the neuroendocrine tumors; this diagnosis has only been given to 2% of the cancers in the US. This cancer can go undiagnosed for a long time due to difficulty in detection and diagnosis. [9]

Whipple's disease, another rare disease on the list, is a bacterial infection that is often mistaken for other diseases, requiring a biopsy of the stomach or duodenum looking for the bacteria Tropheryma whipplei . [10]

Ehlers–Danlos syndromes

The zebra ribbon is also used for awareness of Ehlers–Danlos syndromes, a group of genetic connective tissue illnesses. [11]

See also

Related Research Articles

<span class="mw-page-title-main">Myalgia</span> Location of pain

Myalgia or muscle pain is a painful sensation evolving from muscle tissue. It is a symptom of many diseases. The most common cause of acute myalgia is the overuse of a muscle or group of muscles; another likely cause is viral infection, especially when there has been no injury.

<span class="mw-page-title-main">Ehlers–Danlos syndrome</span> Group of genetic connective tissues disorders

Ehlers–Danlos syndromes (EDS) are a group of 13 genetic connective-tissue disorders. Symptoms often include loose joints, joint pain, stretchy velvety skin, and abnormal scar formation. These may be noticed at birth or in early childhood. Complications may include aortic dissection, joint dislocations, scoliosis, chronic pain, or early osteoarthritis. The current classification was last updated in 2017, when a number of rarer forms of EDS were added.

A rare disease is a disease that affects a small percentage of the population. In some parts of the world, the term orphan disease describes a rare disease whose rarity results in little or no funding or research for treatments, without financial incentives from governments or other agencies. Orphan drugs are medications targeting orphan diseases.

<span class="mw-page-title-main">Zollinger–Ellison syndrome</span> Condition in which tumours stimulate excessive gastric acid production

Zollinger–Ellison syndrome is rare disease in which tumors cause the stomach to produce too much acid, resulting in peptic ulcers. Symptoms include abdominal pain and diarrhea.

<span class="mw-page-title-main">Pancreatic cancer</span> Type of endocrine gland cancer

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known.

<span class="mw-page-title-main">Small-cell carcinoma</span> Type of malignant cancer

Small-cell carcinoma is a type of highly malignant cancer that most commonly arises within the lung, although it can occasionally arise in other body sites, such as the cervix, prostate, and gastrointestinal tract. Compared to non-small cell carcinoma, small cell carcinoma is more aggressive, with a shorter doubling time, higher growth fraction, and earlier development of metastases.

<span class="mw-page-title-main">Birt–Hogg–Dubé syndrome</span> Rare autosomal dominant cancer syndrome

Birt–Hogg–Dubé syndrome (BHD), also Hornstein–Birt–Hogg–Dubé syndrome, Hornstein–Knickenberg syndrome, and fibrofolliculomas with trichodiscomas and acrochordons is a human, adult onset, autosomal dominant genetic disorder caused by a mutation in the folliculin (FLCN) gene. It can cause susceptibility to kidney cancer, renal and pulmonary cysts, and noncancerous tumors of the hair follicles, called fibrofolliculomas. The symptoms seen in each family are unique, and can include any combination of the three symptoms. Fibrofolliculomas are the most common manifestation, found on the face and upper trunk in over 80% of people with BHD over the age of 40. Pulmonary cysts are equally common (84%) and 24% of people with BHD eventually experience a collapsed lung. Kidney tumors, both cancerous and benign, occur in 14–34% of people with BHD; the associated kidney cancers are often rare hybrid tumors.

Zebra is the American medical slang for a surprising, often exotic, medical diagnosis, especially when a more commonplace explanation is more likely. It is shorthand for the aphorism coined in the late 1940s by Theodore Woodward, professor at the University of Maryland School of Medicine, who instructed his medical interns: "When you hear hoofbeats behind you, don't expect to see a zebra." By 1960, the aphorism was widely known in medical circles. The saying is a warning against the statistical base rate fallacy where the likelihood of something like a disease among the population is not taken into consideration for an individual.

<span class="mw-page-title-main">Hypermobility spectrum disorder</span> Heritable connective tissue disorder

Hypermobility spectrum disorder (HSD), related to earlier diagnoses such as hypermobility syndrome (HMS), and joint hypermobility syndrome (JHS) is a heritable connective tissue disorder that affects joints and ligaments. Different forms and sub-types have been distinguished, but it does not include asymptomatic joint hypermobility, sometimes known as double-jointedness.

<span class="mw-page-title-main">Neuroendocrine tumor</span> Medical condition

Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung, and the rest of the body.

Mystery Diagnosis is a television docudrama series that aired on Discovery Health Channel and OWN: Oprah Winfrey Network. Each episode focuses on two or more individuals who have struggled with obscure medical ailments, and their quest for a diagnosis. The program details the patients' and doctors' difficulty in pinpointing a diagnosis; often due to nonspecific symptoms, masquerading syndromes, the rarity of the condition or disease, or the patient's case being an unusual manifestation of said condition or disease.

Uplifting Athletes is a non-profit organization which harnesses the power of sport to build a community that invests in the lives of those affected by rare diseases. The group was established in 2003 and is a 501(c)(3).

<span class="mw-page-title-main">National Organization for Rare Disorders</span> U.S. nonprofit organization

The National Organization for Rare Disorders (NORD) is an American non-profit organization aiming to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers. It was founded in 1983 by Abbey Meyers, along with individuals and rare diseases leaders of rare disease support groups, and it is a 501(c)(3) tax exempt organization.

<span class="mw-page-title-main">Rare Disease Day</span> Observance to raise awareness for rare diseases

Rare Disease Day is an observance held on the last day of February to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. The date is chosen because in leap years it is February 29, the rarest date. The European Organisation for Rare Diseases established the day in 2008 to raise awareness for unknown or overlooked illnesses. According to that organization, treatment for many rare diseases is insufficient, as are the social networks to support individuals with rare diseases and their families; furthermore, while there were already numerous days dedicated to individuals with specific diseases, there had previously not been a day for representing those affected by rare diseases. In 2009, Rare Disease Day went global as the National Organization for Rare Disorders mobilized 200 rare disease patient advocacy organizations in the United States while organizations in China, Australia, Taiwan, and Latin America also lead efforts in their respective countries to coordinate activities and promote the day.

Neuroendocrine carcinoma of the cervix is best defined separately:Neuroendocrine: Of, relating to, or involving the interaction between the nervous system and the hormones of the endocrine glands.Carcinoma: An invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body.

<span class="mw-page-title-main">Pancreatic neuroendocrine tumor</span> Medical condition

Pancreatic neuroendocrine tumours, often referred to as "islet cell tumours", or "pancreatic endocrine tumours" are neuroendocrine neoplasms that arise from cells of the endocrine (hormonal) and nervous system within the pancreas.

Suranjith Seneviratne is a doctor from Sri Lanka who practices in allergology and immunology.

<span class="mw-page-title-main">Ehlers-Danlos Society</span> International patient advocacy and support organization

The Ehlers–Danlos Society is an international nonprofit organization dedicated to patient support, scientific research, advocacy, and increasing awareness for the Ehlers–Danlos syndromes (EDS) and hypermobility spectrum disorder (HSD). The society has organized multiple events around the world in an attempt to raise awareness for EDS and HSD. These events include a rally in Baltimore's Inner Harbor, and a conference in India. The society also organizes symposiums dedicated to research on EDS and HSD. The 2016 symposium resulted in the reclassification of Ehlers–Danlos subtypes. Ehlers-Danlos Society has collaborated with XRP Healthcare to offer a Prescription Savings Card, providing up to 80% off medications for EDS and HSD, including pain relievers and muscle relaxants. Accepted at over 68,000 U.S. pharmacies, including Walmart, CVS, and Walgreens, this partnership offers significant savings.

References

  1. 1 2 Dochitect (2016-04-13). "Hearing hoofbeats: time to think zebras? | Dochitect | Medicine and Architecture Integrated. Healthcare Innovated". Dochitect. Retrieved 2022-07-14.
  2. "NORD Issues New Rare Disease DayⓇ Rallying Cry: Show Your Stripes™!". NORD (National Organization for Rare Disorders). 2019-01-16. Retrieved 2020-06-07.
  3. "February 29th Is The First Rare Disease Day". Medical News Today. 28 February 2008. Retrieved 14 February 2009.
  4. Parisse-Brassens, Jerome (December 2007). "29 February 2008: First European Rare Disease Day". European Organisation for Rare Diseases. Archived from the original on September 29, 2008. Retrieved 14 February 2009.
  5. "History of Rare Disease Day". National Organization for Rare Disorders. 30 January 2024.
  6. Parisse-Brassens, Jerome (December 2007). "29 February 2008: First European Rare Disease Day". European Organisation for Rare Diseases. Archived from the original on May 23, 2009. Retrieved 14 February 2009.
  7. "Le ruban zébré, symbole des maladies rares". La Force dmd (in French). 2019-02-05. Retrieved 2022-07-14.
  8. admin. "List of Rare Disease Information". NORD (National Organization for Rare Disorders). Retrieved 2022-07-14.
  9. "Understanding the Zebras of the Cancer World". Roswell Park Comprehensive Cancer Center. 10 November 2020. Retrieved 2022-07-14.
  10. Klochan, Christen; Anderson, Teresa A.; Rose, Dusten; Dimitrov, Rosen K.; Johnson, Raymond M. (10 October 2013). "Nearly Fatal Case of Whipple's Disease in a Patient Mistakenly on Anti-TNF Therapy". ACG Case Reports Journal. 1 (1): 25–28. doi:10.14309/crj.2013.11. ISSN   2326-3253. PMC   4435267 . PMID   26157813.
  11. EDS-F, Bitterlin (2017-06-13). "Zebra Ribbon". EDS-Foundation Netherlands (in Dutch). Retrieved 2020-06-07.